What is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Its two-receptor mechanism makes it a major focus of current metabolic and weight-regulation research.
Branded vial mockup · packaging may vary
Tirzepatide 5mg
Dual GIP/GLP-1 agonist
Double agonist, double the research interest.
Individual
$18.90
per vial · Currently unavailable
$18.90 · individual vials
COA available with your orderBatch-specific Certificate of Analysis on request →
Fast USA shipping
- Ships from the USA
- Shipping options pending checkout setup
- Batch paperwork with every lot
- Researcher account order history
Payments not yet available
Card payments unavailable
- Purity
- Refer to batch-specific COA
- Form
- Refer to product documentation
- Molecular weight
- 4813.5 g/mol
- Ships from
- USA
Tirzepatide research areas
Tirzepatide measurement calculator
Enter your numbers and get the matching volume and syringe marking.
2. BAC Water Added (mL)
3. Entered amount
Concentration
5 mg/mL
Full draws per vial
5
Math from the values you enter only. Double-check your inputs and syringe markings. For laboratory measurement; not dosing advice.
Handling & storage
Before preparation
Follow the storage conditions supplied for your specific material and batch.
Laboratory preparation
Use a validated laboratory protocol and a compatible solvent. The calculator checks arithmetic, not solvent suitability.
After preparation
Follow compound-specific stability data. A universal storage temperature or shelf life cannot be inferred.
Tirzepatide FAQ
How does tirzepatide differ from semaglutide?
Tirzepatide activates both GIP and GLP-1 receptors; semaglutide targets GLP-1 only.